Supplementation with a Highly Concentrated Docosahexaenoic Acid (DHA) in Non-Proliferative Diabetic Retinopathy: A 2-Year Randomized Double-Blind Placebo-Controlled Study

• Päätekijät: Purificación Piñas García (Tekijä), Francisco Javier Hernández Martínez (Tekijä), Núria Aznárez López (Tekijä), Luis Castillón Torre (Tekijä), Mª Eugenia Tena Sempere (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2022-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

We assessed the effect of a 2-year supplementation with a highly concentrated docosahexaenoic acid (DHA) product with antioxidant activity on non-proliferative diabetic retinopathy (NPDR) in a randomized double-blind placebo-controlled study. A total of 170 patients with diabetes were randomly assig...